Overview
Michael Blake is a primary care provider, practicing in Internal Medicine in Brick, New Jersey. Dr. Blake is rated as an Experienced provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Necrosis, COVID-19, Multisystem Inflammatory Syndrome in Children (MIS-C), Endoscopy, and Gastrostomy.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- EPO
- HMO
- PPO
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
985 Cedar Bridge Avenue, Suite A, Brick, NJ 8723.
Wei Zhao is a primary care provider, practicing in Internal Medicine in Philadelphia, Pennsylvania. Dr. Zhao is rated as a Distinguished provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Microsporidiosis, Lung Adenocarcinoma, Lung Cancer, Coronary Artery Bypass Graft (CABG), and Osteotomy.
Udayan Guha is a primary care provider, practicing in Internal Medicine in New York, New York. Dr. Guha is rated as a Distinguished provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Lung Adenocarcinoma, Thymic Epithelial Tumor, EGFR Positive Lung Cancer, and Lung Cancer.
Fox Chase Cancer Center
Hossein Borghaei is an Oncologist and a Radiologist in Philadelphia, Pennsylvania. Dr. Borghaei is rated as an Elite provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Acute Kidney FailureDr. Blake isDistinguished. Learn about Acute Kidney Failure.
- COVID-19Dr. Blake isDistinguished. Learn about COVID-19.
- Diverticular DiseaseDr. Blake isDistinguished. Learn about Diverticular Disease.
- Low Sodium LevelDr. Blake isDistinguished. Learn about Low Sodium Level.
- Lung MetastasesDr. Blake isDistinguished. Learn about Lung Metastases.
- Multisystem Inflammatory Syndrome in Children (MIS-C)
- Advanced
- Acute PancreatitisDr. Blake isAdvanced. Learn about Acute Pancreatitis.
- ApoplexyDr. Blake isAdvanced. Learn about Apoplexy.
- Atypical PneumoniaDr. Blake isAdvanced. Learn about Atypical Pneumonia.
- CellulitisDr. Blake isAdvanced. Learn about Cellulitis.
- Chronic Obstructive Pulmonary Disease (COPD)
- FaintingDr. Blake isAdvanced. Learn about Fainting.
- Experienced
- Acute CystitisDr. Blake isExperienced. Learn about Acute Cystitis.
- Acute Tubular NecrosisDr. Blake isExperienced. Learn about Acute Tubular Necrosis.
- AgranulocytosisDr. Blake isExperienced. Learn about Agranulocytosis.
- Alcoholic CirrhosisDr. Blake isExperienced. Learn about Alcoholic Cirrhosis.
- Alcoholic KetoacidosisDr. Blake isExperienced. Learn about Alcoholic Ketoacidosis.
- ALK-Positive Non-Small Cell Lung Cancer